Benefits received from pharmaceutical companies
Company |
Reason for receipt of fees |
Total amount received |
Eisai Ltd |
Honorarium for chairing satellite symposium at ENS 2013 |
£2000 - £5000 |
UCB Pharma Ltd |
Speaker for for Epilepsy Masterclass 2013 |
£1000- £2000 |
GSK |
Travel, registration & Accomodation fees to attend AES 2012 |
£1000- £2000 |
Lupin Pharmaceuticals |
Travel expenses, accomodation & speaker honorarium for ENS-Indian Neurological Society teaching course 2012 |
£2000 - £5000 |
Other sources of income or benefits from other organisations relevant to
medical practice
Company |
Reason for receipt of fees |
Total amount received |
Transport for London, Occupational Health |
Neurology Advisor (Average Annual total for medical reports, advice) |
£1000- £2000 |
Past Declarations
Last 2 years (2012-13 covered above). Prior to that since 2009:
2010 GSK, COnsultancy honorarium
2010 Eisai, American Epilepsy Society meeting Registration fee, £276
2011 GSK, Amedican Epilepsy Society meeting, travel, accomodation & registration, £1500
2011 UCB Ltd, Travel & accomodation for Forum of Excellence, epilepsy educational meeting, £450
Other Declarations
Other honoraria and speaker fees (for any work undertaken during employed hours) are paid to St Georges, University of London to support local epilepsy research and education.
Dr Cock also has a medicolegal practice specialising in epilepsy, work for which is undertaken in her own time and never in relation to patients under her care.
Various other roles including external research and publication referee activities, European Neurological Society Teaching Course Director and as Clinical Lead for ebrain are unpaid.